Article
If your turnover on a rolling 3-year average reaches 20%, you will need to explore how you contribute to this.
Urologists perform first remote robot-assisted HIFU for prostate cancer
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
Exploring new avenues in non–muscle invasive bladder cancer treatment
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Neuromodulation device shows promising efficacy for neurogenic bladder
Dose expansion begins in phase 1/2 trial of 67Cu-SAR-bisPSMA in mCRPC